BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $3.529B (100.0% shares, 0.0% debt)

Holdings (7)

G GENPACT LIMITED 33.2%

Value $1.173B Shares 40,538,196 Share Price $28.93 Est. Cost/Share — Unrealized @ Report Date —

— MICHAELS COS INC 28.7%

Value $1.012B Shares 52,798,929 Share Price $19.17 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 11.2%

Value $394M Shares 26,455,651 Share Price $14.90 Est. Cost/Share — Unrealized @ Report Date —

IQV IQVIA HLDGS INC 10.8%

Value $381M Shares 3,815,315 Share Price $99.82 Est. Cost/Share — Unrealized @ Report Date —

— ATENTO S A 9.4%

Value $332M Shares 48,520,671 Share Price $6.85 Est. Cost/Share — Unrealized @ Report Date —

— VERITIV CORP 4.8%

Value $171M Shares 4,283,840 Share Price $39.85 Est. Cost/Share — Unrealized @ Report Date —

— FRANKS INTL N V 1.9%

Value $66.35M Shares 8,506,930 Share Price $7.80 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
G	GENPACT LIMITED	40,538,196	$1.173B	33.2%	$28.93	—	—	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$1.012B	28.7%	$19.17	—	—	COM	59408Q106
SGRY	SURGERY PARTNERS INC	26,455,651	$394M	11.2%	$14.90	—	—	COM	86881A100
IQV	IQVIA HLDGS INC	3,815,315	$381M	10.8%	$99.82	—	—	COM	46266C105
—	ATENTO S A	48,520,671	$332M	9.4%	$6.85	—	—	SHS	L0427L105
—	VERITIV CORP	4,283,840	$171M	4.8%	$39.85	—	—	COM	923454102
—	FRANKS INTL N V	8,506,930	$66.35M	1.9%	$7.80	—	—	COM	N33462107